Literature DB >> 9727919

High prevalence of albuminuria among African-Americans with short duration of diabetes.

L M Thaler, I M El-Kebbi, D C Ziemer, D L Gallina, V G Dunbar, L S Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727919     DOI: 10.2337/diacare.21.9.1576

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

Review 1.  Diabetic nephropathy in African-American patients.

Authors:  Errol D Crook; Sejal R Patel
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

2.  Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Authors:  David C Ziemer; Paul Kolm; Jovonne K Foster; William S Weintraub; Viola Vaccarino; Mary K Rhee; Rincy M Varughese; Circe W Tsui; David D Koch; Jennifer G Twombly; K M Venkat Narayan; Lawrence S Phillips
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

3.  Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

Authors:  Ali Jawa; Senthil Nachimuthu; Merri Pendergrass; Sunil Asnani; Vivian Fonseca
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

4.  Diabetes mellitus and hypertension: key risk factors for kidney disease.

Authors:  Janice P Lea; Susanne B Nicholas
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

5.  Glucose challenge test screening for prediabetes and undiagnosed diabetes.

Authors:  L S Phillips; D C Ziemer; P Kolm; W S Weintraub; V Vaccarino; M K Rhee; R Chatterjee; K M V Narayan; D D Koch
Journal:  Diabetologia       Date:  2009-06-26       Impact factor: 10.122

6.  Incidence and predictors of end stage renal disease among low-income blacks and whites.

Authors:  Loren Lipworth; Michael T Mumma; Kerri L Cavanaugh; Todd L Edwards; T Alp Ikizler; Robert E Tarone; Joseph K McLaughlin; William J Blot
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.